First Public Disclosure of the Environmental Impact Assessment for the “Production Workshop Construction Project of Minhai Biotechnology’s Quadrivalent Inactivated Enterovirus Vaccine (Vero Cell)”

Release date:

2025-06-10

Author:

Source:


Abstract

In accordance with the requirements of the Measures for Public Participation in Environmental Impact Assessment (Order No. 4 of the Ministry of Ecology and Environment), the following information regarding the environmental impact assessment for the “Construction Project of the Production Workshop for Minhai Biotechnology’s Quadrivalent Inactivated Enterovirus Vaccine (Vero Cell)” is hereby made public: I. Project Overview Project Name: Construction of the Production Workshop for Minhai Biotechnology’s Quadrivalent Inactivated Enterovirus Vaccine (Vero Cell) Project Nature: Expansion Construction Site: Building No. 2, Zone 2B, North Factory Area, Beijing Minhai Biotechnology Co., Ltd., No. 35 Simiao Road, Bio‑Pharmaceutical Industry Base, Daxing District, Beijing Project Undertaker: Beijing Minhai Biotechnology Co., Ltd. Scope of Construction: This project will utilize…

  According to the Measures for Public Participation in Environmental Impact Assessment (Ministry of Ecology and Environment No. 4 Order) requires that the “Minhai Biological Quadrivalent Inactivated Enterovirus Vaccine (“ True The environmental impact assessment information for the “Cell Production Workshop Construction Project” is hereby made public as follows:

I. Project Overview

Project Name: Minhai Biologics Quadrivalent Inactivated Enterovirus Vaccine ( True Cell Production Workshop Construction Project

Nature of the project: Expansion

Construction Site: Simiao Road, Biomedical Industry Base, Daxing District, Beijing 35 No. Beijing Minhai Biotechnology Co., Ltd. North Factory Area 2 Production Plant No. 2B district

Construction Entity: Beijing Minhai Biotechnology Co., Ltd.

Construction scope: This project utilizes the facilities of Beijing Minhai Biotechnology Co., Ltd., located on Simiao Road in the Daxing Biomedical Industry Base. 35 Within the North Factory Area 2 Production Plant No. 2B The district, by renovating and upgrading its factory facilities and introducing advanced production equipment, has established a quadrivalent inactivated enterovirus vaccine ( True Cell (original solution) production workshop, Upon completion, the project will have an annual production capacity of 437 liters of inactivated quadrivalent enterovirus vaccine (Vero cell) bulk.

II. Environmental Impact Assessment Agency

This time, Beijing Zhonghuan Shangda Environmental Protection Technology Co., Ltd. has been entrusted with conducting the environmental impact assessment for this project, preparing the relevant EIA documentation, and submitting it to the competent environmental protection administrative authority for approval.

III. Main Issues for Public Consultation

To solicit opinions and suggestions from all sectors of society regarding the project’s environmental protection efforts, this project is hereby made public to gather valuable feedback. Key issues for consideration include: your level of approval of the project’s construction from an environmental perspective; the potential impacts of the project on the surrounding environment and on your work and daily life; and your comments and recommendations on the project’s environmental protection measures.
IV. Main Methods for the Public to Submit Comments

During the public notice period, if the public has any comments or views regarding the project’s construction and the environmental impact assessment, please complete the Public Opinion Form and submit it to the project proponent. Link to download the Public Opinion Form: http://www.mee.gov.cn/xxgk2018/xxgk/xxgk01/201810/t20181024_665329.html Attachment 1

V. Contact Information

Construction Unit: Beijing Minhai Biotechnology Co., Ltd.

Contact: Zhang Yidi

Contact phone number: 15501168808

Email: zhangyidi@biominhai.com

Contact Address: Simiao Road, Biomedical Industry Base, Daxing District, Beijing 35 Number

 

Beijing Minhai Biotechnology Co., Ltd.

                            2025 year 6 month 10 day

 

Recommended Reading


Batch Release Status of the Company’s Products in 2026


The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.


Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.


Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09